Eli Lilly said Thursday that a study showed its experimental diabetes drug, tirzepatide, reduced patients’ blood sugar and body weight more than a rival medicine, Novo Nordisk’s Ozempic.
Investors had been nervously awaiting the result, which was reported in a press release.
About the Author Reprints
When will it be in the public
I would like more information this tirzepatide , thanks
IS IT AVAILABLE!
I have been waiting for a diabetic breakthrough